Advertisement

Acta Neuropathologica

, Volume 119, Issue 6, pp 689–702 | Cite as

Multi-organ distribution of phosphorylated α-synuclein histopathology in subjects with Lewy body disorders

  • Thomas G. Beach
  • Charles H. Adler
  • Lucia I. Sue
  • Linda Vedders
  • LihFen Lue
  • Charles L. White III
  • Haru Akiyama
  • John N. Caviness
  • Holly A. Shill
  • Marwan N. Sabbagh
  • Douglas G. Walker
  • Arizona Parkinson’s Disease Consortium
Original Paper

Abstract

A sensitive immunohistochemical method for phosphorylated α-synuclein was used to stain sets of sections of spinal cord and tissue from 41 different sites in the bodies of 92 subjects, including 23 normal elderly, 7 with incidental Lewy body disease (ILBD), 17 with Parkinson’s disease (PD), 9 with dementia with Lewy bodies (DLB), 19 with Alzheimer’s disease with Lewy bodies (ADLB) and 17 with Alzheimer’s disease with no Lewy bodies (ADNLB). The relative densities and frequencies of occurrence of phosphorylated α-synuclein histopathology (PASH) were tabulated and correlated with diagnostic category. The greatest densities and frequencies of PASH occurred in the spinal cord, followed by the paraspinal sympathetic ganglia, the vagus nerve, the gastrointestinal tract and endocrine organs. The frequency of PASH within other organs and tissue types was much lower. Spinal cord and peripheral PASH was most common in subjects with PD and DLB, where it appears likely that it is universally widespread. Subjects with ILBD had lesser densities of PASH within all regions, but had frequent involvement of the spinal cord and paraspinal sympathetic ganglia, with less-frequent involvement of end-organs. Subjects with ADLB had infrequent involvement of the spinal cord and paraspinal sympathetic ganglia with rare involvement of end-organs. Within the gastrointestinal tract, there was a rostrocaudal gradient of decreasing PASH frequency and density, with the lower esophagus and submandibular gland having the greatest involvement and the colon and rectum the lowest.

Keywords

Parkinson’s disease Parkinsonism Dementia with Lewy bodies Alzheimer’s disease Incidental Lewy bodies α-Synuclein Spinal cord Sympathetic nervous system Peripheral nervous system Autonomic nervous system Enteric nervous system Submandibular gland Esophagus Adrenal gland Heart Stomach Gastrointestinal system 

Notes

Acknowledgments

This research is supported by Grants to the Sun Health Research Institute Brain and Body Donation Program and the Arizona Parkinson’s Disease Consortium by the Michael J. Fox Foundation for Parkinson’s Research (The Prescott Family Initiative), the Arizona Biomedical Research Commission (contracts 4001, 0011 and 05-901) and the National Institute on Aging (Arizona Alzheimer’s Disease Consortium, P30 AG19610). We would like to thank other members of the Arizona Parkinson’s Disease Consortium, including Erika Driver-Dunckley, MD, Virgilio Evidente, MD, and Donald Connor, PhD.

Supplementary material

401_2010_664_MOESM1_ESM.xls (96 kb)
Supplementary material 1 (XLS 96 kb)

References

  1. 1.
    Consensus recommendations for the postmortem diagnosis of Alzheimer’s disease (1997) The National Institute on Aging, and Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer’s Disease Neurobiol Aging 18:S1–S2Google Scholar
  2. 2.
    Abbott RD, Petrovitch H, White LR, Masaki KH, Tanner CM, Curb JD, Grandinetti A, Blanchette PL, Popper JS, Ross GW (2001) Frequency of bowel movements and the future risk of Parkinson’s disease. Neurology 57:456–462PubMedGoogle Scholar
  3. 3.
    Abbott RD, Ross GW, Petrovitch H, Tanner CM, Davis DG, Masaki KH, Launer LJ, Curb JD, White LR (2007) Bowel movement frequency in late-life and incidental Lewy bodies. Mov DisordGoogle Scholar
  4. 4.
    Adler CH (2005) Nonmotor complications in Parkinson’s disease. Mov Disord 20(Suppl 11):S23–S29CrossRefPubMedGoogle Scholar
  5. 5.
    Adler CH, Hentz JG, Joyce JN, Beach T, Caviness JN (2002) Motor impairment in normal aging, clinically possible Parkinson’s disease, and clinically probable Parkinson’s disease: longitudinal evaluation of a cohort of prospective brain donors. Parkinsonism Relat Disord 9:103–110CrossRefPubMedGoogle Scholar
  6. 6.
    Bagheri H, Damase-Michel C, Lapeyre-Mestre M, Cismondo S, O’Connell D, Senard JM, Rascol O, Montastruc JL (1999) A study of salivary secretion in Parkinson’s disease. Clin Neuropharmacol 22:213–215PubMedGoogle Scholar
  7. 7.
    Bateson MC, Gibberd FB, Wilson RS (1973) Salivary symptoms in Parkinson disease. Arch Neurol 29:274–275PubMedGoogle Scholar
  8. 8.
    Beach TG, Adler CH, Lue L, Sue LI, Bachalakuri J, Henry-Watson J, Sasse J, Boyer S, Shirohi S, Brooks R, Eschbacher J, White CL III, Akiyama H, Caviness J, Shill HA, Connor DJ, Sabbagh MN, Walker DG (2009) Unified staging system for Lewy body disorders: correlation with nigrostriatal degeneration, cognitive impairment and motor dysfunction. Acta Neuropathol 117:613–634CrossRefPubMedGoogle Scholar
  9. 9.
    Beach TG, Sue LI, Walker DG, Roher AE, Lue L, Vedders L, Connor DJ, Sabbagh MN, Rogers J (2008) The Sun Health Research Institute Brain Donation Program: description and experience, 1987–2007. Cell Tissue Bank 9:229–245CrossRefPubMedGoogle Scholar
  10. 10.
    Beach TG, White CL, Hamilton RL, Duda JE, Iwatsubo T, Dickson DW, Roncaroli F, Buttini M, Hladik CL, Sue LI, Noorigian JV, Adler CH (2008) Evaluation of alpha-synuclein immunohistochemical methods used by invited experts. Acta Neuropathol 116:277–288CrossRefPubMedGoogle Scholar
  11. 11.
    Beach TG, White CL III, Hladik CL, Sabbagh MN, Connor DJ, Shill HA, Sue LI, Sasse J, Bachalakuri J, Henry-Watson J, Akiyama H, Adler CH (2009) Olfactory bulb alpha-synucleinopathy has high specificity and sensitivity for Lewy body disorders. Acta Neuropathol 117:169–174CrossRefPubMedGoogle Scholar
  12. 12.
    Bloch A, Probst A, Bissig H, Adams H, Tolnay M (2006) Alpha-synuclein pathology of the spinal and peripheral autonomic nervous system in neurologically unimpaired elderly subjects. Neuropathol Appl Neurobiol 32:284–295CrossRefPubMedGoogle Scholar
  13. 13.
    Bouras C, Hof PR, Giannakopoulos P, Michel JP, Morrison JH (1994) Regional distribution of neurofibrillary tangles and senile plaques in the cerebral cortex of elderly patients: a quantitative evaluation of a one-year autopsy population from a geriatric hospital. Cereb Cortex 4:138–150CrossRefPubMedGoogle Scholar
  14. 14.
    Braak H, Bohl JR, Muller CM, Rub U, de Vos RA, Del Tredici K (2006) Stanley Fahn Lecture 2005: the staging procedure for the inclusion body pathology associated with sporadic Parkinson’s disease reconsidered. Mov Disord 21:2042–2051CrossRefPubMedGoogle Scholar
  15. 15.
    Braak H, Braak E (1991) Demonstration of amyloid deposits and neurofibrillary changes in whole brain sections. Brain Pathol 1:213–216CrossRefPubMedGoogle Scholar
  16. 16.
    Braak H, Braak E (1991) Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol (Berl) 82:239–259CrossRefGoogle Scholar
  17. 17.
    Braak H, de Vos RA, Bohl J, Del Tredici K (2006) Gastric alpha-synuclein immunoreactive inclusions in Meissner’s and Auerbach’s plexuses in cases staged for Parkinson’s disease-related brain pathology. Neurosci Lett 396:67–72CrossRefPubMedGoogle Scholar
  18. 18.
    Braak H, Del Tredici K (2008) Invited Article: nervous system pathology in sporadic Parkinson disease. Neurology 70:1916–1925CrossRefPubMedGoogle Scholar
  19. 19.
    Braak H, Ghebremedhin E, Rub U, Bratzke H, Del Tredici K (2004) Stages in the development of Parkinson’s disease-related pathology. Cell Tissue Res 318:121–134CrossRefPubMedGoogle Scholar
  20. 20.
    Braak H, Rub U, Gai WP, Del Tredici K (2003) Idiopathic Parkinson’s disease: possible routes by which vulnerable neuronal types may be subject to neuroinvasion by an unknown pathogen. J Neural Transm 110:517–536CrossRefPubMedGoogle Scholar
  21. 21.
    Braak H, Sastre M, Bohl JR, de Vos RA, Del Tredici K (2007) Parkinson’s disease: lesions in dorsal horn layer I, involvement of parasympathetic and sympathetic pre- and postganglionic neurons. Acta Neuropathol 113:421–429CrossRefPubMedGoogle Scholar
  22. 22.
    Brait K, Fahn S, Schwarz GA (1973) Sporadic and familial parkinsonism and motor neuron disease. Neurology 23:990–1002PubMedGoogle Scholar
  23. 23.
    Caviness JN, Smith BE, Clarke SJ, Adler CH, Caselli RJ, Hentz JG, Manfred MS, Muenter D (2002) Motor unit number estimates in idiopathic Parkinson’s disease. Parkinsonism Relat Disord 8:161–164CrossRefPubMedGoogle Scholar
  24. 24.
    Caviness JN, Smith BE, Stevens JC, Adler CH, Caselli RJ, Reiners CA, Hentz JG, Muenter MD (2000) Motor unit changes in sporadic idiopathic Parkinson’s disease. Mov Disord 15:238–243CrossRefPubMedGoogle Scholar
  25. 25.
    Christensen J, Stiles MJ, Rick GA, Sutherland J (1984) Comparative anatomy of the myenteric plexus of the distal colon in eight mammals. Gastroenterology 86:706–713PubMedGoogle Scholar
  26. 26.
    Danzer KM, Haasen D, Karow AR, Moussaud S, Habeck M, Giese A, Kretzschmar H, Hengerer B, Kostka M (2007) Different species of alpha-synuclein oligomers induce calcium influx and seeding. J Neurosci 27:9220–9232CrossRefPubMedGoogle Scholar
  27. 27.
    Danzer KM, Krebs SK, Wolff M, Birk G, Hengerer B (2009) Seeding induced by alpha-synuclein oligomers provides evidence for spreading of alpha-synuclein pathology. J Neurochem 111:192–203CrossRefPubMedGoogle Scholar
  28. 28.
    Del Tredici K, Rub U, de Vos RA, Bohl JR, Braak H (2002) Where does parkinson disease pathology begin in the brain? J Neuropathol Exp Neurol 61:413–426PubMedGoogle Scholar
  29. 29.
    den Hartog Jager WA, Bethlem J (1960) The distribution of Lewy bodies in the central and autonomic nervous systems in idiopathic paralysis agitans. J Neurol Neurosurg Psychiatry 23:283–290CrossRefGoogle Scholar
  30. 30.
    Desplats P, Lee HJ, Bae EJ, Patrick C, Rockenstein E, Crews L, Spencer B, Masliah E, Lee SJ (2009) Inclusion formation and neuronal cell death through neuron-to-neuron transmission of alpha-synuclein. Proc Natl Acad Sci USA 106:13010–13015CrossRefPubMedGoogle Scholar
  31. 31.
    Duda JE, Giasson BI, Mabon ME, Lee VM, Trojanowski JQ (2002) Novel antibodies to synuclein show abundant striatal pathology in Lewy body diseases. Ann Neurol 52:205–210CrossRefPubMedGoogle Scholar
  32. 32.
    Edwards LL, Quigley EM, Harned RK, Hofman R, Pfeiffer RF (1994) Characterization of swallowing and defecation in Parkinson’s disease. Am J Gastroenterol 89:15–25PubMedGoogle Scholar
  33. 33.
    Fujishiro H, Tsuboi Y, Lin WL, Uchikado H, Dickson DW (2008) Co-localization of tau and alpha-synuclein in the olfactory bulb in Alzheimer’s disease with amygdala Lewy bodies. Acta Neuropathol 116:17–24CrossRefPubMedGoogle Scholar
  34. 34.
    Fujiwara H, Hasegawa M, Dohmae N, Kawashima A, Masliah E, Goldberg MS, Shen J, Takio K, Iwatsubo T (2002) Alpha-synuclein is phosphorylated in synucleinopathy lesions. Nat Cell Biol 4:160–164CrossRefPubMedGoogle Scholar
  35. 35.
    Fumimura Y, Ikemura M, Saito Y, Sengoku R, Kanemaru K, Sawabe M, Arai T, Ito G, Iwatsubo T, Fukayama M, Mizusawa H, Murayama S (2007) Analysis of the adrenal gland is useful for evaluating pathology of the peripheral autonomic nervous system in Lewy body disease. J Neuropathol Exp Neurol 66:354–362CrossRefPubMedGoogle Scholar
  36. 36.
    Gelb DJ, Oliver E, Gilman S (1999) Diagnostic criteria for Parkinson disease. Arch Neurol 56:33–39CrossRefPubMedGoogle Scholar
  37. 37.
    Giasson BI, Duda JE, Forman MS, Lee VM, Trojanowski JQ (2001) Prominent perikaryal expression of alpha- and beta-synuclein in neurons of dorsal root ganglion and in medullary neurons. Exp Neurol 172:354–362CrossRefPubMedGoogle Scholar
  38. 38.
    Hawkes CH, Del Tredici K, Braak H (2007) Parkinson’s disease: a dual-hit hypothesis. Neuropathol Appl Neurobiol 33:599–614CrossRefPubMedGoogle Scholar
  39. 39.
    Hishikawa N, Hashizume Y, Hirayama M, Imamura K, Washimi Y, Koike Y, Mabuchi C, Yoshida M, Sobue G (2000) Brainstem-type Lewy body disease presenting with progressive autonomic failure and lethargy. Clin Auton Res 10:139–143CrossRefPubMedGoogle Scholar
  40. 40.
    Hishikawa N, Hashizume Y, Yoshida M, Sobue G (2003) Clinical and neuropathological correlates of Lewy body disease. Acta Neuropathol 105:341–350PubMedGoogle Scholar
  41. 41.
    Hladik CL, White CL (2003) Comparison of digestive enzyme and formic acid pretreatment for optimal immunohistochemical demonstration of alpha-synuclein-immunoreactive cerebral cortical Lewy neurites. J Neuropathol Exp Neurol 62:554Google Scholar
  42. 42.
    Hopkins DA, Bieger D, deVente J, Steinbusch WM (1996) Vagal efferent projections: viscerotopy, neurochemistry and effects of vagotomy. Prog Brain Res 107:79–96CrossRefPubMedGoogle Scholar
  43. 43.
    Ikemura M, Saito Y, Sengoku R, Sakiyama Y, Hatsuta H, Kanemaru K, Sawabe M, Arai T, Ito G, Iwatsubo T, Fukayama M, Murayama S (2008) Lewy body pathology involves cutaneous nerves. J Neuropathol Exp Neurol 67:945–953CrossRefPubMedGoogle Scholar
  44. 44.
    Iseki E, Marui W, Kosaka K, Akiyama H, Ueda K, Iwatsubo T (1998) Degenerative terminals of the perforant pathway are human alpha-synuclein-immunoreactive in the hippocampus of patients with diffuse Lewy body disease. Neurosci Lett 258:81–84CrossRefPubMedGoogle Scholar
  45. 45.
    Iwanaga K, Wakabayashi K, Yoshimoto M, Tomita I, Satoh H, Takashima H, Satoh A, Seto M, Tsujihata M, Takahashi H (1999) Lewy body-type degeneration in cardiac plexus in Parkinson’s and incidental Lewy body diseases. Neurology 52:1269–1271PubMedGoogle Scholar
  46. 46.
    Jellinger KA (2004) Lewy body-related alpha-synucleinopathy in the aged human brain. J Neural Transm 111:1219–1235CrossRefPubMedGoogle Scholar
  47. 47.
    Kaufmann H, Nahm K, Purohit D, Wolfe D (2004) Autonomic failure as the initial presentation of Parkinson disease and dementia with Lewy bodies. Neurology 63:1093–1095PubMedGoogle Scholar
  48. 48.
    Klos KJ, Ahlskog JE, Josephs KA, Apaydin H, Parisi JE, Boeve BF, DeLucia MW, Dickson DW (2006) Alpha-synuclein pathology in the spinal cords of neurologically asymptomatic aged individuals. Neurology 66:1100–1102CrossRefPubMedGoogle Scholar
  49. 49.
    Knowles CH, De GR, Kapur RP, Bruder E, Farrugia G, Geboes K, Gershon MD, Hutson J, Lindberg G, Martin JE, Meier-Ruge WA, Milla PJ, Smith VV, Vandervinden JM, Veress B, Wedel T (2009) Gastrointestinal neuromuscular pathology: guidelines for histological techniques and reporting on behalf of the Gastro 2009 International Working Group. Acta Neuropathol 118:271–301CrossRefPubMedGoogle Scholar
  50. 50.
    Koike Y, Takahashi A (1997) Autonomic dysfunction in Parkinson’s disease. Eur Neurol 38(Suppl 2):8–12CrossRefPubMedGoogle Scholar
  51. 51.
    Kordower JH, Brundin P (2009) Lewy body pathology in long-term fetal nigral transplants: is Parkinson’s disease transmitted from one neural system to another? Neuropsychopharmacology 34:254CrossRefPubMedGoogle Scholar
  52. 52.
    Kordower JH, Chu Y, Hauser RA, Freeman TB, Olanow CW (2008) Lewy body-like pathology in long-term embryonic nigral transplants in Parkinson’s disease. Nat Med 14:504–506CrossRefPubMedGoogle Scholar
  53. 53.
    Kordower JH, Chu Y, Hauser RA, Olanow CW, Freeman TB (2008) Transplanted dopaminergic neurons develop PD pathologic changes: a second case report. Mov Disord 23:2303–2306CrossRefPubMedGoogle Scholar
  54. 54.
    Kupsky WJ, Grimes MM, Sweeting J, Bertsch R, Cote LJ (1987) Parkinson’s disease and megacolon: concentric hyaline inclusions (Lewy bodies) in enteric ganglion cells. Neurology 37:1253–1255PubMedGoogle Scholar
  55. 55.
    Langston JW (2006) The Parkinson’s complex: parkinsonism is just the tip of the iceberg. Ann Neurol 59:591–596CrossRefPubMedGoogle Scholar
  56. 56.
    Leopold NA, Kagel MC (1997) Pharyngo-esophageal dysphagia in Parkinson’s disease. Dysphagia 12:11–18CrossRefPubMedGoogle Scholar
  57. 57.
    Li JY, Englund E, Holton JL, Soulet D, Hagell P, Lees AJ, Lashley T, Quinn NP, Rehncrona S, Bjorklund A, Widner H, Revesz T, Lindvall O, Brundin P (2008) Lewy bodies in grafted neurons in subjects with Parkinson’s disease suggest host-to-graft disease propagation. Nat Med 14:501–503CrossRefPubMedGoogle Scholar
  58. 58.
    McKeith IG, Dickson DW, Lowe J, Emre M, O’Brien JT, Feldman H, Cummings J, Duda JE, Lippa C, Perry EK, Aarsland D, Arai H, Ballard CG, Boeve B, Burn DJ, Costa D, Del ST, Dubois B, Galasko D, Gauthier S, Goetz CG, Gomez-Tortosa E, Halliday G, Hansen LA, Hardy J, Iwatsubo T, Kalaria RN, Kaufer D, Kenny RA, Korczyn A, Kosaka K, Lee VM, Lees A, Litvan I, Londos E, Lopez OL, Minoshima S, Mizuno Y, Molina JA, Mukaetova-Ladinska EB, Pasquier F, Perry RH, Schulz JB, Trojanowski JQ, Yamada M (2005) Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology 65:1863–1872CrossRefPubMedGoogle Scholar
  59. 59.
    McKeith IG, Galasko D, Kosaka K, Perry EK, Dickson DW, Hansen LA, Salmon DP, Lowe J, Mirra SS, Byrne EJ, Lennox G, Quinn NP, Edwardson JA, Ince PG, Bergeron C, Burns A, Miller BL, Lovestone S, Collerton D, Jansen EN, Ballard C, de Vos RA, Wilcock GK, Jellinger KA, Perry RH (1996) Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology 47:1113–1124PubMedGoogle Scholar
  60. 60.
    Miki Y, Mori F, Wakabayashi K, Kuroda N, Orimo S (2009) Incidental Lewy body disease restricted to the heart and stellate ganglia. Mov Disord 24:2299–2301CrossRefPubMedGoogle Scholar
  61. 61.
    Minguez-Castellanos A, Chamorro CE, Escamilla-Sevilla F, Ortega-Moreno A, Rebollo AC, Gomez-Rio M, Concha A, Munoz DG (2007) Do alpha-synuclein aggregates in autonomic plexuses predate Lewy body disorders? A cohort study. Neurology 68:2012–2018CrossRefPubMedGoogle Scholar
  62. 62.
    Mirra SS, Heyman A, McKeel D, Sumi SM, Crain BJ, Brownlee LM, Vogel FS, Hughes JP, van Belle G, Berg L (1991) The Consortium to Establish a Registry for Alzheimer’s Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer’s disease. Neurology 41:479–486PubMedGoogle Scholar
  63. 63.
    O’Sullivan SS, Holton JL, Massey LA, Williams DR, Revesz T, Lees AJ (2008) Parkinson’s disease with Onuf’s nucleus involvement mimicking multiple system atrophy. J Neurol Neurosurg Psychiatry 79:232–234CrossRefPubMedGoogle Scholar
  64. 64.
    Parkkinen L, Pirttila T, Alafuzoff I (2008) Applicability of current staging/categorization of alpha-synuclein pathology and their clinical relevance. Acta Neuropathol 115:399–407CrossRefPubMedGoogle Scholar
  65. 65.
    Persson M, Osterberg T, Granerus AK, Karlsson S (1992) Influence of Parkinson’s disease on oral health. Acta Odontol Scand 50:37–42CrossRefPubMedGoogle Scholar
  66. 66.
    Pfeiffer RF (2003) Gastrointestinal dysfunction in Parkinson’s disease. Lancet Neurol 2:107–116CrossRefPubMedGoogle Scholar
  67. 67.
    Pinnington LL, Muhiddin KA, Ellis RE, Playford ED (2000) Non-invasive assessment of swallowing and respiration in Parkinson’s disease. J Neurol 247:773–777CrossRefPubMedGoogle Scholar
  68. 68.
    Proulx M, de Courval FP, Wiseman MA, Panisset M (2005) Salivary production in Parkinson’s disease. Mov Disord 20:204–207CrossRefPubMedGoogle Scholar
  69. 69.
    Qualman SJ, Haupt HM, Yang P, Hamilton SR (1984) Esophageal Lewy bodies associated with ganglion cell loss in achalasia. Similarity to Parkinson’s disease. Gastroenterology 87:848–856PubMedGoogle Scholar
  70. 70.
    Saito Y, Kawashima A, Ruberu NN, Fujiwara H, Koyama S, Sawabe M, Arai T, Nagura H, Yamanouchi H, Hasegawa M, Iwatsubo T, Murayama S (2003) Accumulation of phosphorylated alpha-synuclein in aging human brain. J Neuropathol Exp Neurol 62:644–654PubMedGoogle Scholar
  71. 71.
    Saito Y, Ruberu NN, Sawabe M, Arai T, Kazama H, Hosoi T, Yamanouchi H, Murayama S (2004) Lewy body-related alpha-synucleinopathy in aging. J Neuropathol Exp Neurol 63:742–749PubMedGoogle Scholar
  72. 72.
    Sica RE, Herskovits E, Aguilera N, Poch G (1973) An electrophysiological investigation of skeletal muscle in Parkinson’s disease. J Neurol Sci 18:411–420CrossRefPubMedGoogle Scholar
  73. 73.
    Sica RE, Sanz OP (1976) An electrophysiological study of the functional changes in the spinal motoneurones in Parkinson’s disease. Electromyogr Clin Neurophysiol 16:409–417PubMedGoogle Scholar
  74. 74.
    Siddiqui MF, Rast S, Lynn MJ, Auchus AP, Pfeiffer RF (2002) Autonomic dysfunction in Parkinson’s disease: a comprehensive symptom survey. Parkinsonism Relat Disord 8:277–284CrossRefPubMedGoogle Scholar
  75. 75.
    Takeda S, Yamazaki K, Miyakawa T, Arai H (1993) Parkinson’s disease with involvement of the parasympathetic ganglia. Acta Neuropathol 86:397–398CrossRefPubMedGoogle Scholar
  76. 76.
    Tumilasci OR, Cersosimo MG, Belforte JE, Micheli FE, Benarroch EE, Pazo JH (2006) Quantitative study of salivary secretion in Parkinson’s disease. Mov Disord 21:660–667CrossRefPubMedGoogle Scholar
  77. 77.
    Uchikado H, Lin WL, DeLucia MW, Dickson DW (2006) Alzheimer disease with amygdala Lewy bodies: a distinct form of alpha-synucleinopathy. J Neuropathol Exp Neurol 65:685–697CrossRefPubMedGoogle Scholar
  78. 78.
    Verbaan D, Marinus J, Visser M, van Rooden SM, Stiggelbout AM, van Hilten JJ (2007) Patient-reported autonomic symptoms in Parkinson disease. Neurology 69:333–341CrossRefPubMedGoogle Scholar
  79. 79.
    Wakabayashi K, Takahashi H (1997) The intermediolateral nucleus and Clarke’s column in Parkinson’s disease. Acta Neuropathol 94:287–289CrossRefPubMedGoogle Scholar
  80. 80.
    Wakabayashi K, Takahashi H, Ohama E, Ikuta F (1990) Parkinson’s disease: an immunohistochemical study of Lewy body-containing neurons in the enteric nervous system. Acta Neuropathol 79:581–583CrossRefPubMedGoogle Scholar
  81. 81.
    Wakabayashi K, Takahashi H, Takeda S, Ohama E, Ikuta F (1988) Parkinson’s disease: the presence of Lewy bodies in Auerbach’s and Meissner’s plexuses. Acta Neuropathol 76:217–221CrossRefPubMedGoogle Scholar
  82. 82.
    Zaccai J, Brayne C, McKeith I, Matthews F, Ince PG (2008) Patterns and stages of alpha-synucleinopathy: relevance in a population-based cohort. Neurology 70:1042–1048CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag 2010

Authors and Affiliations

  • Thomas G. Beach
    • 1
  • Charles H. Adler
    • 2
  • Lucia I. Sue
    • 1
  • Linda Vedders
    • 1
  • LihFen Lue
    • 1
  • Charles L. White III
    • 3
  • Haru Akiyama
    • 4
  • John N. Caviness
    • 2
  • Holly A. Shill
    • 1
  • Marwan N. Sabbagh
    • 1
  • Douglas G. Walker
    • 1
  • Arizona Parkinson’s Disease Consortium
  1. 1.Sun Health Research InstituteSun CityUSA
  2. 2.Mayo ClinicScottsdaleUSA
  3. 3.University of Texas Southwestern Medical CenterDallasUSA
  4. 4.Tokyo Institute of PsychiatryTokyoJapan

Personalised recommendations